title: Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis.
abstract: Members of the family Picornaviridae, in particular, enteroviruses, represent a serious threat to human health. They are responsible for numerous pathologies ranging from mild disease to fatal outcome. Due to the limited number of safe and effective antivirals against enteroviruses, there is a need for search and development of novel drugs with various mechanisms of activity against enteroviruses-induced pathologies. We studied the effect of dihydroquercetin (DHQ), a flavonoid from larch wood, on the course of pancreatitis of white mice caused by coxsackievirus B4 (CVB4). DHQ was applied intraperitoneally at doses of 75 or 150 mg/kg/day once a day for 5 days postinfection (p.i.) starting on day 1 p.i., and its effect was compared to that of the reference compound ribavirin. The application of DHQ resulted in a dose-dependent decrease in the virus titer in pancreatic tissue, reaching, at the highest dose, 2.4 logs on day 5 p.i. Also, the application of DHQ led to restoration of antioxidant activity of pancreatic tissue that was impaired in the course of pancreatitis. Morphologically, pancreatic tissue of DHQ-treated animals demonstrated less infiltration with inflammatory cells and no signs of tissue destruction compared to placebo-treated mice. Both ribavirin- and DHQ-treated animals developed fewer foci of pancreatic inflammation per mouse, and these foci contained fewer infiltrating cells than those in placebo-treated mice. The effect of DHQ was comparable to or exceeded that of ribavirin. Taken together, our results suggest high antiviral activity of DHQ and its promising potential in complex treatment of viral pancreatitis.
authors.affiliation: Influenza Research Institute, St. Petersburg, Russia.
authors.forename: Anastasia V
authors.initials: AV
authors.lastname: Galochkina
authors.affiliation: Influenza Research Institute, St. Petersburg, Russia.
authors.forename: Vadim B
authors.initials: VB
authors.lastname: Anikin
authors.affiliation: Irkutsk Institute of Chemistry, Irkutsk, Russia.
authors.forename: Vasily A
authors.initials: VA
authors.lastname: Babkin
authors.affiliation: Irkutsk Institute of Chemistry, Irkutsk, Russia.
authors.forename: Liudmila A
authors.initials: LA
authors.lastname: Ostrouhova
authors.affiliation: Influenza Research Institute, St. Petersburg, Russia. zarubaev@influenza.spb.ru.
authors.forename: Vladimir V
authors.initials: VV
authors.lastname: Zarubaev
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D029822:Enterovirus B, Human / Q000187:drug effects; D005260:Female; D028221:Larix / Q000737:chemistry*; D051379:Mice; D015394:Molecular Structure; D010179:Pancreas / Q000821:virology; D010195:Pancreatitis / Q000188:drug therapy / Q000821:virology*; D011794:Quercetin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D011897:Random Allocation; D012254:Ribavirin / Q000008:administration & dosage / Q000494:pharmacology; D014779:Virus Replication / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D011794:Quercetin; C003377:taxifolin